Related Experiment Video
Updated: May 30, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth
David A Foster1, Paige Yellen, Limei Xu
1Department of Biological Sciences, Hunter College of The City University of New York, New York, NY, USA.
Abstract:
Most genetic changes that promote tumorigenesis involve dysregulation of G1 cell cycle progression. A key regulatory site in G1 is a growth factor-dependent restriction point (R) where cells commit to mitosis. In addition to the growth factor-dependent "R," which maps to a site about 3.5 hours after mitosis, there is another checkpoint later in G1 that is dependent on nutritional sufficiency that has also been referred to as R. However, this second site in late G1 can be distinguished both temporally and genetically from R. We are proposing that the late G1 regulatory site be more appropriately referred to as a "cell growth" checkpoint to distinguish it from R. This checkpoint, which likely has an evolutionary relationship to the yeast cell cycle checkpoint START, is regulated by signals governed by mTOR, the mammalian target of rapamycin. This review summarizes evidence that distinguishes R from the proposed cell growth checkpoint. Since both checkpoints are dysregulated in most, if not all, human cancers, distinguishing between these 2 distinct G1 regulatory checkpoints has significance for rational therapeutic strategies targeting oncogenic signals.
Insights
Most cancers disrupt cell cycle progression. This review distinguishes the growth factor-dependent restriction point (R) from a distinct nutrient-sensing cell growth checkpoint, crucial for understanding tumorigenesis.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Genetic alterations driving tumorigenesis frequently disrupt G1 cell cycle progression.
- A critical G1 regulatory point is the growth factor-dependent restriction point (R), committing cells to mitosis.
- A second, later G1 checkpoint responsive to nutritional status has also been termed R, causing confusion.
Purpose of the Study:
- To differentiate the canonical restriction point (R) from a distinct, nutrient-sensitive G1 checkpoint.
- To propose renaming the late G1 checkpoint as the 'cell growth' checkpoint for clarity.
- To highlight the significance of distinguishing these checkpoints for cancer therapeutic strategies.
Main Methods:
- Review of existing scientific literature and evidence.
- Comparative analysis of temporal and genetic characteristics of the two G1 regulatory sites.
- Examination of the role of mTOR signaling in the proposed cell growth checkpoint.
Main Results:
- Evidence presented distinguishes the growth factor-dependent restriction point (R) from a later, nutrient-dependent checkpoint.
- The later checkpoint is proposed to be regulated by mammalian target of rapamycin (mTOR) signaling.
- This late G1 checkpoint shares evolutionary links with the yeast cell cycle START checkpoint.
Conclusions:
- The late G1 regulatory site should be designated the 'cell growth' checkpoint to avoid confusion with R.
- Dysregulation of both R and the cell growth checkpoint is implicated in most human cancers.
- Clarifying the distinction between these checkpoints is vital for developing targeted cancer therapies.
Related Concept Videos
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System
The Cell Cycle Control System
Cells Coordinate Growth and Proliferation
Cells Coordinate Growth and Proliferation
Negative Regulator Molecules

